These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 8485065)

  • 1. Renal effects of xamoterol in patients with moderate heart failure.
    Bøtker HE; Jensen HK; Krusell LR; Sørensen EV
    Cardiovasc Drugs Ther; 1993 Feb; 7(1):111-6. PubMed ID: 8485065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiotensin II AT1 receptor antagonism prevents detrimental renal actions of acute diuretic therapy in human heart failure.
    Chen HH; Redfield MM; Nordstrom LJ; Cataliotti A; Burnett JC
    Am J Physiol Renal Physiol; 2003 May; 284(5):F1115-9. PubMed ID: 12676739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of renal neutral endopeptidase inhibition on sodium excretion, renal hemodynamics and neurohormonal activation in patients with congestive heart failure.
    Kimmelstiel CD; Perrone R; Kilcoyne L; Souhrada J; Udelson J; Smith J; de Bold A; Griffith J; Konstam MA
    Cardiology; 1996; 87(1):46-53. PubMed ID: 8631044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms of sodium retention in heart failure: relation to the renin-angiotensin-aldosterone system.
    Eiskjaer H; Bagger JP; Danielsen H; Jensen JD; Jespersen B; Thomsen K; Sørensen SS; Pedersen EB
    Am J Physiol; 1991 Jun; 260(6 Pt 2):F883-9. PubMed ID: 1647690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of the chronic effects of oral xamoterol and enalapril on blood pressure and renal function in mild to moderate heart failure.
    Jamieson MJ; Webster J; Fowler G; Rawles J; Smith FW; Petrie JC
    Br J Clin Pharmacol; 1991 Mar; 31(3):305-12. PubMed ID: 1675867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vasopressin-2-receptor antagonism augments water excretion without changes in renal hemodynamics or sodium and potassium excretion in human heart failure.
    Costello-Boerrigter LC; Smith WB; Boerrigter G; Ouyang J; Zimmer CA; Orlandi C; Burnett JC
    Am J Physiol Renal Physiol; 2006 Feb; 290(2):F273-8. PubMed ID: 16189291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of rapamycin on renal hemodynamics, water and sodium excretion, and plasma levels of angiotensin II, aldosterone, atrial natriuretic peptide, and vasopressin in pigs.
    Golbaekdal K; Nielsen CB; Djurhuus JC; Pedersen EB
    Transplantation; 1994 Dec; 58(11):1153-7. PubMed ID: 7992354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute and chronic hemodynamic effects of xamoterol in mild to moderate congestive heart failure.
    Virk SJ; Qiang FX; Anfilogoff NH; Murray RG; Littler WA; Davies MK
    Am J Cardiol; 1991 May; 67(12):48C-52C; discussion 52C-54C. PubMed ID: 1673587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal and hormonal actions of atrial natriuretic peptide during angiotensin II or noradrenaline infusion in man.
    Eiskjaer H; Nielsen CB; Sørensen SS; Pedersen EB
    Eur J Clin Invest; 1996 Jul; 26(7):584-95. PubMed ID: 8864421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glomerular and tubular antinatriuretic actions of low-dose angiotensin II infusion in man.
    Eiskjaer H; Sørensen SS; Danielsen H; Pedersen EB
    J Hypertens; 1992 Sep; 10(9):1033-40. PubMed ID: 1328362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of diltiazem hydrochloride upon sodium diuresis and renal function in chronic congestive heart failure.
    Kinoshita M; Kusukawa R; Shimono Y; Motomura M; Tomonaga G; Hoshino T
    Arzneimittelforschung; 1979; 29(4):676-81. PubMed ID: 582767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety of concomitant potassium-sparing diuretics in angiotensin-converting enzyme inhibitor therapy in severe congestive heart failure. Xamoterol in Severe Heart Failure Study Group.
    Bergler-Klein J; Sochor H; Pouleur H; Pacher R; Porenta G; Glogar D
    J Cardiovasc Pharmacol; 1994 Aug; 24(2):194-8. PubMed ID: 7526050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hemodynamic and humoral changes following intravenous administration of xamoterol in patients with heart failure and coronary heart disease].
    Erlemeier HH; Kupper W; Bleifeld W
    Z Kardiol; 1990 Feb; 79(2):126-33. PubMed ID: 1969685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of intense angiotensin II suppression on the diuretic response to furosemide during chronic ACE inhibition.
    Good JM; Brady AJ; Noormohamed FH; Oakley CM; Cleland JG
    Circulation; 1994 Jul; 90(1):220-4. PubMed ID: 8026000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of pinacidil on renal haemodynamics, tubular function and plasma levels of angiotensin II, aldosterone and atrial natriuretic peptide in healthy man.
    Nielsen CB; Pedersen EB
    Eur J Clin Pharmacol; 1993; 45(1):29-35. PubMed ID: 8405026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal and hormonal effects and tolerance of an ANP analogue in healthy man.
    Eiskjaer H; Schmiegelow M; Jespersen B; Tietze IN; Jensen JD; Sørensen SS; Thomsen K; Pedersen EB
    Eur J Clin Pharmacol; 1991; 41(6):547-54. PubMed ID: 1840038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal effects of low dose prazosin in patients with congestive heart failure.
    Lang CC; Choy AM; Rahman AR; Struthers AD
    Eur Heart J; 1993 Sep; 14(9):1245-52. PubMed ID: 8223740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determinants of the initial effects of captopril on blood pressure, glomerular filtration rate, and natriuresis in mild-to-moderate chronic congestive heart failure secondary to coronary artery disease.
    Motwani JG; Fenwick MK; Morton JJ; Struthers AD
    Am J Cardiol; 1994 Jun; 73(16):1191-6. PubMed ID: 8203337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardio-renal effects of the A1 adenosine receptor antagonist SLV320 in patients with heart failure.
    Mitrovic V; Seferovic P; Dodic S; Krotin M; Neskovic A; Dickstein K; de Voogd H; Böcker C; Ziegler D; Godes M; Nakov R; Essers H; Verboom C; Hocher B
    Circ Heart Fail; 2009 Nov; 2(6):523-31. PubMed ID: 19919976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of high dose atrial natriuretic peptide on renal haemodynamics, sodium handling and hormones in cirrhotic patients with and without ascites.
    Jespersen B; Eiskjaer H; Jensen JD; Mogensen CE; Sørensen SS; Pedersen EB
    Scand J Clin Lab Invest; 1995 Jul; 55(4):273-87. PubMed ID: 7569729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.